Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Int J Epidemiol. 2013 Aug;42(4):1100-10. doi: 10.1093/ije/dyt122. Epub 2013 Aug 6.
In the past, upward shifts of the so-called Preston curve, which relates life expectancy to national income, have contributed importantly to worldwide increases in life expectancy. These shifts were due to rapid diffusion of knowledge and technology for infectious disease control from high-income to low-income countries. We assessed to what extent life expectancy growth in Europe has been accompanied by upward shifts in the relation between national income and life expectancy in later parts of the 20th century, when progress in cardiovascular disease control was the main driver of life expectancy growth.
Data on national income (gross domestic product per capita, in 1990 international dollars), life expectancy and cause-specific mortality covering the period 1900-2008 were extracted from international data banks. (Change in) life expectancy and age-standardized mortality was regressed on (change in) national income, and the regression parameters were used to estimate the contribution to rising life expectancy and declining mortality in Europe as a whole of changes in national income vs shifts in the relation between national income and health outcomes.
Large upward shifts in the relation between national income and life expectancy only occurred before 1960, and were due to rapid declines in mortality from infectious diseases which were independent of rises in national income. These shifts account for between two-thirds and four-fifths of the increase in life expectancy in Europe as a whole during this period. After 1960, upward shifts in the relation between national income and life expectancy were much smaller, and contributed only between one-quarter and one-half to the increase in life expectancy in Europe as a whole. During the latter period, declines in mortality from cardiovascular disease were mainly attributable to increases in national income.
In contrast to earlier periods, recent life expectancy growth in European countries appears to have been dependent on their economic growth. More rapid diffusion of knowledge and technology for cardiovascular disease control from higher- to lower-income countries in Europe may be needed to close the East-West life expectancy gap, but it is unlikely that this can be achieved in the absence of more equal economic conditions.
过去,与国民收入相关的所谓普雷斯顿曲线(表示预期寿命与国民收入关系的曲线)的上升对全球预期寿命的增长做出了重要贡献。这些变化是由于传染病控制方面的知识和技术从高收入国家向低收入国家的快速传播。我们评估了在 20 世纪后期,当心血管疾病控制方面的进展成为预期寿命增长的主要驱动因素时,欧洲的预期寿命增长在多大程度上伴随着国民收入与预期寿命之间关系的上升。
从国际数据库中提取了 1900 年至 2008 年期间的国民收入(人均国内生产总值,以 1990 年国际元为单位)、预期寿命和死因特异性死亡率的数据。用(国民收入的)变化来回归(预期寿命和年龄标准化死亡率的)变化,并使用回归参数来估计整个欧洲国民收入的变化以及国民收入与健康结果之间关系的变化对上升的预期寿命和下降的死亡率的贡献。
只有在 1960 年之前,国民收入与预期寿命之间的关系才出现了较大的上升,这是由于传染病死亡率的迅速下降,而这种下降与国民收入的上升无关。这些变化解释了整个欧洲在这一时期预期寿命增长的三分之二到五分之四。1960 年后,国民收入与预期寿命之间关系的上升幅度要小得多,对整个欧洲预期寿命增长的贡献仅为四分之一到二分之一。在这一时期后期,心血管疾病死亡率的下降主要归因于国民收入的增加。
与早期相比,欧洲国家最近的预期寿命增长似乎依赖于它们的经济增长。需要更迅速地从欧洲较高收入国家向较低收入国家传播心血管疾病控制方面的知识和技术,以缩小东西方预期寿命差距,但如果没有更平等的经济条件,这种情况不太可能实现。